ストックスクリーナーアプリを入手
68.94
0.96%
-0.67
前日終値:
$69.61
開ける：
$69.47
24時間の取引高:
2.17M
Relative Volume:
0.99
時価総額：
$33.62B
収益：
$10.63B
当期純損益:
$819.00M
株価収益率:
41.59
EPS:
1.6577
ネットキャッシュフロー:
$1.59B
1週間 パフォーマンス:
+1.52%
1か月 パフォーマンス:
+2.74%
6か月 パフォーマンス:
-14.87%
1年 パフォーマンス:
-21.26%
1日の値動き範囲:
$68.26
$69.48
1週間の範囲:
$67.23
$70.31
52週間の値動き範囲:
$61.84
$90.41
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
68.94 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
353.33 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
165.70 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.28 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
211.00 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-26 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 開始されました | William Blair | Mkt Perform |
| 2026-01-20 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-09 | ダウングレード | Stifel | Buy → Hold |
| 2025-12-11 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-08-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-05-20 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 繰り返されました | BTIG Research | Buy |
| 2025-03-28 | 繰り返されました | Needham | Buy |
| 2025-03-25 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-01-24 | 繰り返されました | Needham | Buy |
| 2025-01-10 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 繰り返されました | Needham | Buy |
| 2024-11-12 | 繰り返されました | Needham | Buy |
| 2024-10-10 | アップグレード | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 開始されました | Goldman | Buy |
| 2024-03-14 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 開始されました | Bernstein | Outperform |
| 2023-12-18 | ダウングレード | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 開始されました | Stifel | Buy |
| 2023-12-04 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-05-10 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | アップグレード | Societe Generale | Sell → Hold |
| 2022-12-22 | 開始されました | Mizuho | Buy |
| 2022-11-17 | ダウングレード | Societe Generale | Hold → Sell |
| 2022-08-11 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-05-13 | 再開されました | Credit Suisse | Outperform |
| 2022-05-12 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 開始されました | Needham | Buy |
| 2022-03-11 | 開始されました | BofA Securities | Buy |
| 2022-01-18 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 開始されました | Oppenheimer | Perform |
| 2021-07-14 | 開始されました | Deutsche Bank | Buy |
| 2021-05-06 | アップグレード | Citigroup | Sell → Neutral |
| 2021-03-22 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-11-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-07-06 | ダウングレード | Citigroup | Neutral → Sell |
| 2020-07-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-04-08 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Argus | Hold → Buy |
| 2020-03-24 | アップグレード | Societe Generale | Sell → Hold |
| 2020-03-13 | アップグレード | UBS | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-26 | アップグレード | Berenberg | Hold → Buy |
| 2020-01-08 | 開始されました | Argus | Hold |
| 2019-10-29 | 開始されました | Stephens | Equal-Weight |
| 2019-08-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-06-24 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-06-14 | 開始されました | BTIG Research | Neutral |
| 2019-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-05-02 | 開始されました | Credit Suisse | Outperform |
すべてを表示
Alcon Inc (ALC) 最新ニュース
Alcon stock trades steadily as surgical vision business underpins earnings growth - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader builds on profitable growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as ophthalmic specialist reports higher 2024 revenue and margin improvem - Ad-hoc-news.de
Systane Ultra by Alcon Incdry eye relief anchored in a broad product line - Ad-hoc-news.de
Alcon stock trades steadily as ophthalmic leader focuses on growth and margins - Ad-hoc-news.de
Alcon Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh Revenue Breakdown – BMFBOVESPA:A2LC34 - TradingView
Alcon stock holds as 2025 revenue and margin growth guide the story - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts higher 2024 revenue and margins - Ad-hoc-news.de
Alcon stock trades steadily as earnings and eye care demand support valuation - Ad-hoc-news.de
Alcon stock holds steady as investors await fresh catalyst - AD HOC NEWS
Alcon | 7/24/26 - ktnv.com
Alcon gets you seeing in time for school - WSBT
Alcon: Back-to-School eye exams. What every parent should know. - KHGI
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal S - GuruFocus
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India - PR Newswire
Alcon stock trades steady as eye care specialist builds on 2025 growth and higher margins - Ad-hoc-news.de
Systane Complete by Alcon Inc.dry eye relief built on oil-based drops - AD HOC NEWS
ALC|Alcon AG|Price:67.270|Chg%:-0.640 - TradingKey
Alcon stock trades steadily as surgical eye care revenue grows - AD HOC NEWS
ALC stock trades steadily as Alcon lifts 2024 outlook on stronger surgical and vision care demand - Ad-hoc-news.de
Enterprise value to revenue forward of Alcon AG – SIX:ALC - TradingView
Alcon stock trades steadily as recent earnings highlight margin and growth mix - Ad-hoc-news.de
Alcon (SWX:ALC) Stock Looks Undervalued On Cash Flow But Fair On Earnings - Yahoo Finance
Alcon stock supported by steady growth and surgical demand - Ad-hoc-news.de
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35 - GuruFocus
ALC|Alcon AG|Price:67.210| - TradingKey
Alcon stock holds its ground as 2025 sales and profit metrics frame the 22 July 2026 setup - Ad-hoc-news.de
Sight Sciences wins $34M patent ruling against Alcon - MSN
The Systane Ultra Lubricant Eye Drops. Dry-eye care with a long shelf presence - Ad-hoc-news.de
Alcon stock trades steady as recent earnings highlight margin and growth dynamics - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts rising revenue and margins - Ad-hoc-news.de
Alcon stock steadies as surgical eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades steadily as surgical vision business supports earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye-care growth supports earnings - Ad-hoc-news.de
Mexican Gold Mining Corp. and Alcon Silver Corp. Complete Arrangement to Create Platauro Metals Corp., a Diversified Precious Metals Exploration Company - TMX Newsfile
Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Alcon stock trades steadily as surgical eye care growth supports earnings outlook - Ad-hoc-news.de
Price to book forward of Alcon AG – BX:2U3 - TradingView
Alcon stock trades steadily as eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades near recent highs as surgical vision demand supports growth - Ad-hoc-news.de
Alcon stock trades steadily as eye care group highlights Q1 2026 growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as eye care leader builds on solid revenue growth - Ad-hoc-news.de
Alcon stock steadies as investors weigh surgical vision growth and recent earnings trends - Ad-hoc-news.de
Alcon stock trades steady as eye-care margins support growth outlook - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports margins - ad-hoc-news.de
Systane Augentropfen by Alcon Inc.dry-eye relief built on medical data - ad-hoc-news.de
Alcon stock trades steady as vision care group focuses on margin and growth after 2025 earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports recent earnings - ad-hoc-news.de
Alcon stock trades steady as latest earnings show margin resilience - ad-hoc-news.de
Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $80 - Moomoo
Alcon stock holds steady as eye-care demand supports the long-term growth story - ad-hoc-news.de
Alcon Inc (ALC) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
1.60%
大文字化:
|
ボリューム (24 時間):